Neuroendocrine Prostate Cancer
5 clinical trials · Condition
◉ Watch Neuroendocrine Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer (NCT04702737) | Amgen | 2021-06-10 |
| Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors (NCT02709889) | AbbVie | 2016-09-23 |
| A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer (NCT01799278) | Weill Medical College of Cornell University | 2013-02-01 |
Track Neuroendocrine Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.